Key clinical point: Compared with standard treatment, intensive blood pressure reduction provides a nonsignificant reduction of recurrent stroke risk.
Major finding: The rate of recurrent stroke was 1.65% in the intensive treatment group and 2.26% in the standard treatment group.
Study details: A randomized, open-label trial of 1,263 patients with a history of stroke in the previous 3 years.
Disclosures: This study was sponsored by Biomedis International.
Kitagawa K et al. ISC 2019, Abstract LB10.